4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-17-024729
CIK 0001492426operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:14 PM ET
Size
9.1 KB
Accession
0001209191-17-024729
Insider Transaction Report
Form 4
HAMPTON GEORGE P
See remarks
Transactions
- Exercise/Conversion
Ordinary Shares
2017-04-01+7,000→ 27,663 total - Tax Payment
Ordinary Shares
2017-04-01$14.78/sh−2,937$43,409→ 24,726 total - Exercise/Conversion
Restricted Stock Units
2017-04-01−7,000→ 14,000 total→ Ordinary Shares (7,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The number of Issuer ordinary shares previously reported as beneficially owned by the reporting person was incorrectly overreported on a prior Form 4 by 672 shares and has been corrected with this filing.
- [F3]On April 1, 2015 and May 1, 2015, the reporting person was granted an aggregate of 28,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on the April 1, 2016.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:14 PM ET
- Size
- 9.1 KB